Lilly eczema trials open doors to new treatment hope
Eczema remains one of the most common chronic skin conditions, yet its impact is not evenly distributed. For many African American patients, the condition presents differently, lasts longer, and is often underdiagnosed or mismanaged. New clinical research, including trials backed by Eli Lilly and Company, is beginning to address these gaps while expanding access to […]